Great customer service helps a business succeed despite a harsh economic climate or new technology phases, according to an article in Forbes:
The Latest
The medical device market is replete with new advances and is growing bigger each year. Global Spine Marketing Manager at Invibio Michael Veldman discusses some of the most exciting opportunities and developments in the spine-focuses device market today.
Mainstay Medical has received authorization from the Medicines and Healthcare Products Regulatory Agency and the Central Ethics Committee to expand the clinical trial of ReActiv8 to include clinical trial sites in the United Kingdom.
Hagerstown, Md.-based Parkway Neuroscience and Spine Institute added Stuart J. Goodman, MD, to its medical team.
Cabell Huntington Hospital in Huntington, W.Va., added Paul Muizelaar, MD, PhD, a fellowship-trained neurosurgeon to its physician team.
MedStar Orthopaedics has added Andrew Abramowitz, MD, to the medical staff at MedStar Franklin Square Medical Center in Baltimore.
Mesoblast, a company focused on regenerative medicine, plans to launch its first stem cell therapy product in Japan next year and then the United States in 2016, according to a report from The Australian.
As healthcare shifts from fee-for-service to pay-for-performance and risk-sharing compensation models, specialists are developing new and innovative ways to ensure their field's sustainability in the future. Spine is no different — and in many ways, spine surgeons have an uphill…
The Food and Drug Administration cleared 35 orthopedic and spine devices in June.
Texas Children's Hospital in Houston sent physicians and reserachers to present at the American College of Surgeons National Surgical Quality Improvement Program conference.